Guangyao Shan

8PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)Solid tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 20, 2026
Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.

|Feb 09, 2026
Retinol-driven Gene Signatures Predict Lung Adenocarcinoma Outcomes and Highlight PAICS as a Therapeutic Opportunity.

Guangyao Shan, Binyang Pan, Yongxing Zhang

|Nov 11, 2025
Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Yunyi Bian, Guangyao Shan, Guoshu Bi

|Sep 02, 2025
Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC.

Guoshu Bi, Jiaqi Liang, Yunyi Bian

|May 15, 2023
Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells.

Guoshu Bi, Jiaqi Liang, Guangyao Shan

|Feb 16, 2023
Characterization of Infiltrating Immune Cells and Secretory or Membrane-Associated Proteins in KRAS Lung Adenocarcinoma.

Yunyi Bian, Guoshu Bi, Guangyao Shan

Pageof 2

Frequent Collaborators

7 joint publications

Jiaqi Liang

6 joint publications

Guoshu Bi

6 joint publications

Qun Wang

5 joint publications

Cheng Zhan